Reduced phosphodiesterase 3 activity and phosphodiesterase 3A level in synthetic vascular smooth muscle cells: implications for use of phosphodiesterase 3 inhibitors in cardiovascular tissues.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples